Find your path to Michele
27 people in our graph share verified history with Michele β schools, employers, funds. One of them is your warm intro.
Carolyn BrownunlockedMichele: together at University of Maryland (2001β2004)
Γ5Michele: together at University of Maryland
Michele: together at Axovant Sciences
Γ3Michele: together at Kriya Therapeutics
Chief Scientific Officer at Kriya Therapeutics
Intro paths
β
In turn, Michele can intro founders to Kriya Therapeutics's investors below.
Kriya Therapeutics's investors Β· 9
Alumni VenturesManchester Β· $100K β $10M checks Β· since 2025AmploHouston Β· since 2025Amplo VenturesSpring Β· since 2021Bluebird VenturesPalo Alto Β· since 2021Foresite CapitalWest Hollywood Β· since 2021JDRF T1D FundBoston Β· since 2021Narya CapitalColumbus Β· since 2021Patient Square CapitalMenlo Park Β· since 2021Premji InvestMenlo Park Β· since 2021
Co-founders at Kriya Therapeutics
SR

Shankar RamaswamyCo-Founder, Chairman & CEO
RJ

Roger JeffsCo-Founder & Vice Chairman
FW

Fraser WrightScientific Co-Founder & Chief Gene Therapy Officer
SR

Shankar Ramaswamy, M.D.Founder
Experience
- Kriya TherapeuticsChief Scientific Officercurrent2022 β presentUnited States
- Kriya TherapeuticsSenior Vice President Research and Development2020 β 2022Raleigh-Durham-Chapel Hill Area
- Maono Consulting LLCPresident, Senior Consultantcurrent2018 β presentRaleigh-Durham, North Carolina Area
- Axovant Gene Therapies, LtdVice President, Early Development2019 β 2020RTP North Carolina
- Axovant SciencesSenior Director, Head Nonclincal2018 β 2019Raleigh-Durham, North Carolina Area
- Liquidia TechnologiesExecutive Director Vaccines2015 β 2018RTP, NC
- Liquidia TechnologiesDirector Vaccines2012 β 2014RTP NC
- AerasDirector2008 β 2012
- Canon U.S. Life SciencesSenior Scientist2005 β 2008
- Aeras Global TB Vaccine FoundationScientist2004 β 2005Rockville, MD
- University of MarylandPost Doc2001 β 2004
Skills & more
VaccinesBiotechnologyCell CultureImmunologyMolecular BiologyLifesciencesCellMicrobiologyBiochemistryPCRProtein ChemistryCell Biology
+12 more
Assay DevelopmentImmunoassaysELISAScienceVirologyPurificationGenomicsRT-PCRLaboratoryAnalytical ChemistryqPCRDNAFrom Michele's professional profile.
Frequently asked questions
- Who is Michele Stone?
- Chief Scientific Officer at Kriya Therapeutics
- Where does Michele Stone work?
- Michele Stone is Chief Scientific Officer at Kriya Therapeutics.
- Where did Michele Stone go to school?
- Michele Stone studied at University of Maryland Baltimore (Doctor of Philosophy - PhD, Biochemistry and Molecular Biology); University of Lynchburg (BS, chemistry); Central Virginia Community College (AAAS, Science).
Same school
Also attended University of Maryland Baltimore2
Also attended University of Lynchburg3
Shared employers
Also worked at Kriya Therapeutics6
Also worked at Axovant Gene Therapies, Ltd3
Also worked at Liquidia Technologies13
Luke RoushCo-Founder, Co-CEO, and Board Member at Sovereigns Capital VentureElizabeth KellyManaging Director at Pappas CapitalStephen BlochGeneral Partner at Canaan PartnersGinger RothrockInvestor at HG VenturesSajith WickramasekaraFounder/CEO at BenchlingJodi SieFund Controller at Rice
+ 7 more



























